新冠病毒感染后发生的白癜风：一例病例报告及病理生理学综述 - Suppr

Suppr

超能文献

Vitiligo following COVID-19: A case report and review of pathophysiology.

作者信息

Schmidt Alexandra F, Rubin Alexandra, Milgraum David, Wassef Cindy

机构信息

Robert Wood Johnson Medical School, Rutgers University, Piscataway, New Jersey.

Department of Dermatology, Robert Wood Johnson Medical School, New Brunswick, New Jersey.

出版信息

JAAD Case Rep. 2022 Apr;22:47-49. doi: 10.1016/j.jdcr.2022.01.030. Epub 2022 Feb 10.

DOI:10.1016/j.jdcr.2022.01.030

PMID:35169601

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8830139/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fed/8927906/e9678acc4a40/gr1.jpg

相似文献

Vitiligo following COVID-19: A case report and review of pathophysiology.

JAAD Case Rep. 2022 Apr;22:47-49. doi: 10.1016/j.jdcr.2022.01.030. Epub 2022 Feb 10.

A new-onset vitiligo following the inactivated COVID-19 vaccine.

J Cosmet Dermatol. 2022 Feb;21(2):429-430. doi: 10.1111/jocd.14677. Epub 2021 Dec 15.

Treatment recommendations for patients with vitiligo during COVID-19.

Australas J Dermatol. 2021 Aug;62(3):e481-e482. doi: 10.1111/ajd.13610. Epub 2021 May 24.

Autoimmune Encephalitis After SARS-CoV-2 Infection: Case Frequency, Findings, and Outcomes.

Neurology. 2021 Dec 7;97(23):e2262-e2268. doi: 10.1212/WNL.0000000000012931. Epub 2021 Oct 11.

Case of vitiligo universalis as a sequela of drug-induced hypersensitivity syndrome.

J Dermatol. 2021 Jan;48(1):92-95. doi: 10.1111/1346-8138.15562. Epub 2020 Nov 12.

Vitiligo as the Presenting Manifestation of Sjogren's Syndrome: Case Report and Review of Vitiligo and Its Associated Autoimmune Conditions.

Cureus. 2020 Oct 29;12(10):e11250. doi: 10.7759/cureus.11250.

Rhododendrol-induced leukoderma update II: Pathophysiology, mechanisms, risk evaluation, and possible mechanism-based treatments in comparison with vitiligo.

J Dermatol. 2021 Jul;48(7):969-978. doi: 10.1111/1346-8138.15878. Epub 2021 May 5.

Vitiligo and melanoma-associated hypopigmentation (MAH): shared and discriminative features.

J Dtsch Dermatol Ges. 2008 Dec;6(12):1053-9. doi: 10.1111/j.1610-0387.2008.06755.x. Epub 2008 May 7.

Beneficial effects of multi-disciplinary rehabilitation in postacute COVID-19: an observational cohort study.

Eur J Phys Rehabil Med. 2021 Apr;57(2):189-198. doi: 10.23736/S1973-9087.21.06549-7. Epub 2021 Jan 15.

Vitiligo Possibly Triggered by COVID-19 Vaccination.

Cureus. 2022 Jan 3;14(1):e20902. doi: 10.7759/cureus.20902. eCollection 2022 Jan.

引用本文的文献

Targeted therapies induced depigmentation: a review.

Front Immunol. 2025 Aug 8;16:1625738. doi: 10.3389/fimmu.2025.1625738. eCollection 2025.

Long-Term Risk of Autoimmune and Autoinflammatory Connective Tissue Disorders Following COVID-19.

JAMA Dermatol. 2024 Dec 1;160(12):1278-1287. doi: 10.1001/jamadermatol.2024.4233.

Recent Advances in the Use of Cubosomes as Drug Carriers with Special Emphasis on Topical Applications.

J Lipids. 2024 Jul 10;2024:2683466. doi: 10.1155/2024/2683466. eCollection 2024.

Post-COVID pigment loss: the connection between vitiligo and the pandemic.

Postepy Dermatol Alergol. 2024 Apr;41(2):197-202. doi: 10.5114/ada.2024.138670. Epub 2024 Apr 9.

Presentation of vitiligo in a case of COVID-19 infection concomitant with receiving remdesivir.

Clin Case Rep. 2024 Mar 11;12(3):e8646. doi: 10.1002/ccr3.8646. eCollection 2024 Mar.

Impact of COVID-19 Vaccine and COVID-19 Infection on Vitiligo Activity and Progression.

Clin Cosmet Investig Dermatol. 2023 Dec 15;16:3581-3587. doi: 10.2147/CCID.S439045. eCollection 2023.

A case of vitiligo after COVID-19 vaccination: a possible role of thymic dysfunction.

J Zhejiang Univ Sci B. 2023 Dec 15;24(12):1141-1150. doi: 10.1631/jzus.B2300025.

Vitiligo Following COVID-19 Vaccination and Primary Infection: A Case Report and Systematic Review.

Cureus. 2023 Sep 19;15(9):e45546. doi: 10.7759/cureus.45546. eCollection 2023 Sep.

Autoimmune and Autoinflammatory Connective Tissue Disorders Following COVID-19.

JAMA Netw Open. 2023 Oct 2;6(10):e2336120. doi: 10.1001/jamanetworkopen.2023.36120.

Childhood vitiligo developing after COVID-19 infection.

Dermatol Reports. 2023 Jun 6;15(3):9547. doi: 10.4081/dr.2023.9547. eCollection 2023 Sep 12.

本文引用的文献

Sudden onset of vitiligo after COVID-19 vaccine.

Dermatol Ther. 2022 Jan;35(1):e15196. doi: 10.1111/dth.15196. Epub 2021 Nov 15.

New-onset vitiligo following mRNA-1273 (Moderna) COVID-19 vaccination.

Clin Case Rep. 2021 Sep 26;9(9):e04865. doi: 10.1002/ccr3.4865. eCollection 2021 Sep.

COVID-19 and Oxidative Stress.

Biochemistry (Mosc). 2020 Dec;85(12):1543-1553. doi: 10.1134/S0006297920120068.

The triggering of post-COVID-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune reconstitution in susceptible individuals.

Med Hypotheses. 2020 Dec;145:110345. doi: 10.1016/j.mehy.2020.110345. Epub 2020 Oct 14.

Autoimmune and inflammatory diseases following COVID-19.

Nat Rev Rheumatol. 2020 Aug;16(8):413-414. doi: 10.1038/s41584-020-0448-7.

Vitiligo: A Review.

Dermatology. 2020;236(6):571-592. doi: 10.1159/000506103. Epub 2020 Mar 10.

Vitiligo Pathogenesis and Emerging Treatments.

Dermatol Clin. 2017 Apr;35(2):257-265. doi: 10.1016/j.det.2016.11.014.

Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up.

J Am Acad Dermatol. 2011 Sep;65(3):473-491. doi: 10.1016/j.jaad.2010.11.061.

Late onset vitiligo: a study of 182 patients.

Int J Dermatol. 2005 Mar;44(3):193-6. doi: 10.1111/j.1365-4632.2004.01948.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Vitiligo following COVID-19: A case report and review of pathophysiology.

JAAD Case Rep. 2022 Apr;22:47-49. doi: 10.1016/j.jdcr.2022.01.030. Epub 2022 Feb 10.

A new-onset vitiligo following the inactivated COVID-19 vaccine.

J Cosmet Dermatol. 2022 Feb;21(2):429-430. doi: 10.1111/jocd.14677. Epub 2021 Dec 15.

Treatment recommendations for patients with vitiligo during COVID-19.

Australas J Dermatol. 2021 Aug;62(3):e481-e482. doi: 10.1111/ajd.13610. Epub 2021 May 24.

Autoimmune Encephalitis After SARS-CoV-2 Infection: Case Frequency, Findings, and Outcomes.

Neurology. 2021 Dec 7;97(23):e2262-e2268. doi: 10.1212/WNL.0000000000012931. Epub 2021 Oct 11.

Case of vitiligo universalis as a sequela of drug-induced hypersensitivity syndrome.

J Dermatol. 2021 Jan;48(1):92-95. doi: 10.1111/1346-8138.15562. Epub 2020 Nov 12.

Vitiligo as the Presenting Manifestation of Sjogren's Syndrome: Case Report and Review of Vitiligo and Its Associated Autoimmune Conditions.

Cureus. 2020 Oct 29;12(10):e11250. doi: 10.7759/cureus.11250.

Rhododendrol-induced leukoderma update II: Pathophysiology, mechanisms, risk evaluation, and possible mechanism-based treatments in comparison with vitiligo.

J Dermatol. 2021 Jul;48(7):969-978. doi: 10.1111/1346-8138.15878. Epub 2021 May 5.

Vitiligo and melanoma-associated hypopigmentation (MAH): shared and discriminative features.

J Dtsch Dermatol Ges. 2008 Dec;6(12):1053-9. doi: 10.1111/j.1610-0387.2008.06755.x. Epub 2008 May 7.

Beneficial effects of multi-disciplinary rehabilitation in postacute COVID-19: an observational cohort study.

Eur J Phys Rehabil Med. 2021 Apr;57(2):189-198. doi: 10.23736/S1973-9087.21.06549-7. Epub 2021 Jan 15.

Vitiligo Possibly Triggered by COVID-19 Vaccination.

Cureus. 2022 Jan 3;14(1):e20902. doi: 10.7759/cureus.20902. eCollection 2022 Jan.

引用本文的文献

Targeted therapies induced depigmentation: a review.

Front Immunol. 2025 Aug 8;16:1625738. doi: 10.3389/fimmu.2025.1625738. eCollection 2025.

Long-Term Risk of Autoimmune and Autoinflammatory Connective Tissue Disorders Following COVID-19.

JAMA Dermatol. 2024 Dec 1;160(12):1278-1287. doi: 10.1001/jamadermatol.2024.4233.

Recent Advances in the Use of Cubosomes as Drug Carriers with Special Emphasis on Topical Applications.

J Lipids. 2024 Jul 10;2024:2683466. doi: 10.1155/2024/2683466. eCollection 2024.

Post-COVID pigment loss: the connection between vitiligo and the pandemic.

Postepy Dermatol Alergol. 2024 Apr;41(2):197-202. doi: 10.5114/ada.2024.138670. Epub 2024 Apr 9.

Presentation of vitiligo in a case of COVID-19 infection concomitant with receiving remdesivir.

Clin Case Rep. 2024 Mar 11;12(3):e8646. doi: 10.1002/ccr3.8646. eCollection 2024 Mar.

Impact of COVID-19 Vaccine and COVID-19 Infection on Vitiligo Activity and Progression.

Clin Cosmet Investig Dermatol. 2023 Dec 15;16:3581-3587. doi: 10.2147/CCID.S439045. eCollection 2023.

A case of vitiligo after COVID-19 vaccination: a possible role of thymic dysfunction.

J Zhejiang Univ Sci B. 2023 Dec 15;24(12):1141-1150. doi: 10.1631/jzus.B2300025.

Vitiligo Following COVID-19 Vaccination and Primary Infection: A Case Report and Systematic Review.

Cureus. 2023 Sep 19;15(9):e45546. doi: 10.7759/cureus.45546. eCollection 2023 Sep.

Autoimmune and Autoinflammatory Connective Tissue Disorders Following COVID-19.

JAMA Netw Open. 2023 Oct 2;6(10):e2336120. doi: 10.1001/jamanetworkopen.2023.36120.

Childhood vitiligo developing after COVID-19 infection.

Dermatol Reports. 2023 Jun 6;15(3):9547. doi: 10.4081/dr.2023.9547. eCollection 2023 Sep 12.

本文引用的文献

Sudden onset of vitiligo after COVID-19 vaccine.

Dermatol Ther. 2022 Jan;35(1):e15196. doi: 10.1111/dth.15196. Epub 2021 Nov 15.

New-onset vitiligo following mRNA-1273 (Moderna) COVID-19 vaccination.

Clin Case Rep. 2021 Sep 26;9(9):e04865. doi: 10.1002/ccr3.4865. eCollection 2021 Sep.

COVID-19 and Oxidative Stress.

Biochemistry (Mosc). 2020 Dec;85(12):1543-1553. doi: 10.1134/S0006297920120068.

The triggering of post-COVID-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune reconstitution in susceptible individuals.

Med Hypotheses. 2020 Dec;145:110345. doi: 10.1016/j.mehy.2020.110345. Epub 2020 Oct 14.

Autoimmune and inflammatory diseases following COVID-19.

Nat Rev Rheumatol. 2020 Aug;16(8):413-414. doi: 10.1038/s41584-020-0448-7.

Vitiligo: A Review.

Dermatology. 2020;236(6):571-592. doi: 10.1159/000506103. Epub 2020 Mar 10.

Vitiligo Pathogenesis and Emerging Treatments.

Dermatol Clin. 2017 Apr;35(2):257-265. doi: 10.1016/j.det.2016.11.014.

Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up.

J Am Acad Dermatol. 2011 Sep;65(3):473-491. doi: 10.1016/j.jaad.2010.11.061.

Late onset vitiligo: a study of 182 patients.

Int J Dermatol. 2005 Mar;44(3):193-6. doi: 10.1111/j.1365-4632.2004.01948.x.